Long-term debt · 2011–2025
Halozyme Therapeutics long-term debt
$2.1B+42.3% · FY2025
Halozyme Therapeutics (HALO) reported $2.1B in long-term debt for fiscal 2025, +42.3% year on year.
| Fiscal year | Long-term debt | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $2.1B | +42.3% | Open → |
| FY20242024-12-31 | $1.5B | +0.4% | Open → |
| FY20232023-12-31 | $1.5B | +0.4% | Open → |
| FY20222022-12-31 | $1.5B | +89.6% | Open → |
| FY20212021-12-31 | $787M | +$787M | Open → |
| FY20202020-12-31 | $0 | −100.0% | Open → |
| FY20192019-12-31 | $383M | +998.4% | Open → |
| FY20182018-12-31 | $34.9M | −72.1% | Open → |
| FY20172017-12-31 | $125M | −37.2% | Open → |
| FY20162016-12-31 | $199M | +612.3% | Open → |
| FY20152015-12-31 | $28.0M | −43.9% | Open → |
| FY20142014-12-31 | $49.9M | +0.2% | Open → |
| FY20132013-12-31 | $49.8M | +67.8% | Open → |
| FY20122012-12-31 | $29.7M | +$29.7M | Open → |
| FY20112011-12-31 | $0 | — | Open → |
Long-term debt — Long-term debt is borrowing due more than a year out. A large figure is normal for capital-intensive businesses and says nothing on its own about financial health.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026
Long-term debt at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Halozyme Therapeutics long-term debt |url=https://companiesranked.com/en/company/halozyme-therapeutics/long-term-debt |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Halozyme Therapeutics long-term debt. CompaniesRanked. https://companiesranked.com/en/company/halozyme-therapeutics/long-term-debtBibTeX
@misc{companiesranked-en-company-halozyme-therapeutics-long-term-debt-2026,
author = {{CompaniesRanked}},
title = {{Halozyme Therapeutics long-term debt}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/halozyme-therapeutics/long-term-debt}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001159036-26-000104 · August 6, 2026
{{cite web |title=Halozyme Therapeutics long-term debt — 10-Q (0001159036-26-000104) |url=https://www.sec.gov/Archives/edgar/data/1159036/000115903626000104/halo-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-06}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.